BACKGROUND & AIMS: Although the Hedgehog (Hh) pathway regulates development and progression of several types of cancer, its involvement in colon cancer remains unclear. We aimed to clarify the roles of Hh signaling in intestinal tumorigenesis. METHODS: We studied expression of the Hh signaling components in the intestinal tumors of Apc(+/Delta716) mouse, a model for familial adenomatous polyposis. We used small interfering RNAs against Smoothened (SMO), which encodes the major signal transducer of the Hh pathway, to knockdown SMO expression and explore its function in human colon cancer cell lines. We also compared the intestinal tumor phenotypes of Apc(+/Delta716)Smo(+/-) mice with those of Apc(+/Delta716) mice. RESULTS: Expression of Smo was markedly increased in the intestinal adenoma epithelium of Apc(+/Delta716) mice. Importantly, SMO knockdown in human colon cancer cell lines suppressed proliferation in culture; cells arrested at the G1/S phase. Furthermore, Apc(+/Delta716)Smo(+/-) mice had decreased numbers of polyps in the large size class (Phi >or= 1-2 mm) and recessed polyp morphology, accompanied by reduced proliferation of the tumor epithelial cells. Unexpectedly, reduced expression of Smo suppressed beta-catenin-dependent transcription, rather than Hh-responsive Gli-dependent transcription. Interestingly, SMO knockdown reduced protein levels of active beta-catenin and induced its nuclear exclusion. CONCLUSIONS: Smo contributes to intestinal tumorigenesis by increasing Wnt signaling. SMO might be a good therapeutic target for patients with colorectal polyps and carcinomas, even in the absence of Hh signal activation.
BACKGROUND & AIMS: Although the Hedgehog (Hh) pathway regulates development and progression of several types of cancer, its involvement in colon cancer remains unclear. We aimed to clarify the roles of Hh signaling in intestinal tumorigenesis. METHODS: We studied expression of the Hh signaling components in the intestinal tumors of Apc(+/Delta716) mouse, a model for familial adenomatous polyposis. We used small interfering RNAs against Smoothened (SMO), which encodes the major signal transducer of the Hh pathway, to knockdown SMO expression and explore its function in humancolon cancer cell lines. We also compared the intestinal tumor phenotypes of Apc(+/Delta716)Smo(+/-) mice with those of Apc(+/Delta716) mice. RESULTS: Expression of Smo was markedly increased in the intestinal adenoma epithelium of Apc(+/Delta716) mice. Importantly, SMO knockdown in humancolon cancer cell lines suppressed proliferation in culture; cells arrested at the G1/S phase. Furthermore, Apc(+/Delta716)Smo(+/-) mice had decreased numbers of polyps in the large size class (Phi >or= 1-2 mm) and recessed polyp morphology, accompanied by reduced proliferation of the tumor epithelial cells. Unexpectedly, reduced expression of Smo suppressed beta-catenin-dependent transcription, rather than Hh-responsive Gli-dependent transcription. Interestingly, SMO knockdown reduced protein levels of active beta-catenin and induced its nuclear exclusion. CONCLUSIONS:Smo contributes to intestinal tumorigenesis by increasing Wnt signaling. SMO might be a good therapeutic target for patients with colorectal polyps and carcinomas, even in the absence of Hh signal activation.
Authors: Fabian T Schneider; Anne Schänzer; Cathrin J Czupalla; Sonja Thom; Knut Engels; Mirko H H Schmidt; Karl H Plate; Stefan Liebner Journal: Am J Pathol Date: 2010-05-27 Impact factor: 4.307
Authors: Juliana M Xavier-Ferrucio; Fernando Vieira Pericole; Matheus Rodrigues Lopes; Paulo Latuf-Filho; Karin Spät Albino Barcellos; Amanda Inácio Dias; Paula de Melo Campos; Fabiola Traina; Jose Vassallo; Sara Teresinha Olalla Saad; Patricia Favaro Journal: Haematologica Date: 2015-08-20 Impact factor: 9.941
Authors: Tingting Li; Xiaoyun Liao; Paul Lochhead; Teppei Morikawa; Mai Yamauchi; Reiko Nishihara; Kentaro Inamura; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Aya Kuchiba; Yu Imamura; Yoshifumi Baba; Kaori Shima; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Shuji Ogino; Zhi Rong Qian Journal: Ann Surg Oncol Date: 2014-07-15 Impact factor: 5.344
Authors: Toshinori Hinoue; Daniel J Weisenberger; Fei Pan; Mihaela Campan; Myungjin Kim; Joanne Young; Vicki L Whitehall; Barbara A Leggett; Peter W Laird Journal: PLoS One Date: 2009-12-21 Impact factor: 3.240
Authors: Kwon-Sik Park; Luciano G Martelotto; Martin Peifer; Martin L Sos; Anthony N Karnezis; Moe R Mahjoub; Katie Bernard; Jamie F Conklin; Anette Szczepny; Jing Yuan; Ribo Guo; Beatrice Ospina; Jeanette Falzon; Samara Bennett; Tracey J Brown; Ana Markovic; Wendy L Devereux; Cory A Ocasio; James K Chen; Tim Stearns; Roman K Thomas; Marion Dorsch; Silvia Buonamici; D Neil Watkins; Craig D Peacock; Julien Sage Journal: Nat Med Date: 2011-10-09 Impact factor: 53.440